#ABAF15NZ Speaker – Allan May
Meet the speakers #ABAF15NZ – Allan May
The 2015 Asian Business Angel Forum is our country’s big opportunity to meet and build connections with some of the world’s most successful and insightful investors from around the world.
As a founder of Life Science Angels (LSA), focused solely on medical device and biotech startups, Allan has curated a group comprised of high net worth individuals who are veterans from the medical device or biotech fields in the US.
The group have, since 2005, invested over $35M in 32 early stage companies who have gained over $700M in follow-on funding. The LSA portfolio also boasts five favourable exits.
Allan’s experience spans founder, CEO, board member and Chairman roles on a number of early stage companies in life sciences – including Intella Interventional Systems, MAST Immunosystems, ImmuneTech, Athenagen (Comentis), Nanostim, nSpine, and BioMimedica. In 2007 Allan joined renowned inventor, entrepreneur and cardiac surgeon, Dr. Thomas Fogarty, in co-founding Emergent Medical Partners. EMP is a boutique venture fund focused on early stage medical device company creation and investing. It has made 25 investments to date with 4 successful exits, including eValve and Ardian.
In 2010, Allan was elected Chairman of the Board of the Kauffman Foundation’s Angel Capital Education Foundation, now known as the Angel Resource Institute. ARI is devoted to the promotion and study of angel investing.
A strong advocate for developing angel investing as a complex ecosystem of peer-to-peer support and mentorship and also the formalization of angel investment engines, Allan has been outspoken on the benefits early-stage investing to the growth of ecosystems. For instance in a 2011 piece for The Atlantic he goes so far as to say angels were key to ‘saving Silicon Valley’; operating as they do on the clear understanding “capitalism still works, and the higher the risk the higher the return”.
Allan began his academic career at Case Western Reserve University where he received his Juris Doctorate. He earned a Bachelor of Arts degree in 1969 from Kent State University and is a graduate of the Stanford Executive Program for Small Business. Allan now frequents conferences and government programs as a lecturer on trends and developments affecting investing in life science. He has co-chaired Singularity University’s Innovation and Entrepreneurship Track at its FutureMed Program and is a member of the editorial board of Elsevier Windhover’s In Vivo magazine.
Allan brings to New Zealand insights from his extensive background of involvement in negotiating mergers, acquisitions, strategic alliances and successfully completing transactions with both public and private companies.
Meet Allan along with New Zealand’s angel investment community and other thought leaders from over a dozen countries by securing your seat now at one the southern hemisphere’s largest international exclusive investor events Asian Business Angels Forum, Queenstown, New Zealand.